HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New updates in the world of hepatitis C virus infected organ transplantation.

AbstractPURPOSE OF REVIEW:
With the advent of direct acting antiviral (DAA) therapy, the use of organs from hepatitis C virus infected (HCV+) donors is gaining more traction. In this review, we aim to: provide an overview of recent literature that supports the use of HCV+ organs, outline ongoing challenges to the use of these organs, and highlight the areas within this field where active investigation is ongoing.
RECENT FINDINGS:
The present review describes clinical outcomes related to the transplantation of both HCV+ nonviremic and viremic organs and the distinction between hepatic and nonhepatic transplants. It also discusses the current debate pertaining to the ideal treatment strategy for donor-derived HCV infection, that is pre-emptive therapy versus prophylaxis therapy.
SUMMARY:
Data suggest that the use of HCV+ organs is an effective and relatively well tolerated strategy to combat the organ scarcity. However, clinicians must be vigilant to a signal of increased inflammation as HCV+ organ transplantation becomes more universal. Recent studies suggest that shorter courses of DAA may sufficiently treat donor-derived HCV infection, however the best treatment approach to minimize risk, cost, and toxicity is still under investigation.
AuthorsKatya Prakash, Saima Aslam
JournalCurrent opinion in organ transplantation (Curr Opin Organ Transplant) Vol. 25 Issue 4 Pg. 364-370 (08 2020) ISSN: 1531-7013 [Electronic] United States
PMID32520787 (Publication Type: Journal Article, Review)
Chemical References
  • Antiviral Agents
Topics
  • Antiviral Agents (therapeutic use)
  • Hepacivirus (drug effects, isolation & purification)
  • Hepatitis C (drug therapy, epidemiology, virology)
  • Hepatitis C, Chronic (drug therapy, epidemiology, virology)
  • Humans
  • Living Donors (statistics & numerical data)
  • Organ Transplantation (methods, statistics & numerical data)
  • Tissue and Organ Procurement (methods)
  • Viremia (drug therapy, epidemiology, virology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: